Projected disease burden and treatment eligibility of patients with diffuse large B-cell and mantle cell lymphoma in the United States over the next decade
{{output}}
Introduction: There is lack of comprehensive and up-to-date forecasted estimates for diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL), with inconsistencies in existing literature. The study estimated and forec... ...
